Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

991 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors.
Zattarin E, Presti D, Mariani L, Sposetti C, Leporati R, Menichetti A, Corti C, Benvenuti C, Fucà G, Lobefaro R, Ligorio F, Provenzano L, Vingiani A, Del Vecchio M, Griguolo G, Sirico M, Bernocchi O, Marra A, Zagami P, Agostinetto E, Jacobs F, Di Mauro P, Esposito A, Giorgi CA, Lalli L, Boldrini L, Giacchetti PPB, Schianca AC, Guarneri V, Pedersini R, Losurdo A, Zambelli A, Generali D, Criscitiello C, Curigliano G, Pruneri G, de Braud F, Dieci MV, Vernieri C. Zattarin E, et al. Among authors: marra a. NPJ Breast Cancer. 2023 Apr 17;9(1):27. doi: 10.1038/s41523-023-00534-1. NPJ Breast Cancer. 2023. PMID: 37069173 Free PMC article.
P-170 Glycoprotein (MDR) and p53 Expression in Breast Cancer.
Ciaparrone M, Terribile D, Curigliano G, Marra A, Sgambato A, Boninsegna A, Masetti R, Carbone A, Flamini G, Picciocchi A, Cittadini A. Ciaparrone M, et al. Among authors: marra a. Breast J. 1998 Jul;4(4):270-6. doi: 10.1046/j.1524-4741.1998.440270.x. Breast J. 1998. PMID: 21223447
What therapies are on the horizon for HER2 positive breast cancer?
Viale G, Morganti S, Ferraro E, Zagami P, Marra A, Curigliano G. Viale G, et al. Among authors: marra a. Expert Rev Anticancer Ther. 2019 Sep;19(9):811-822. doi: 10.1080/14737140.2019.1660164. Epub 2019 Aug 28. Expert Rev Anticancer Ther. 2019. PMID: 31448640 Review.
Expression of tumor-associated antigens in breast cancer subtypes.
Curigliano G, Bagnardi V, Ghioni M, Louahed J, Brichard V, Lehmann FF, Marra A, Trapani D, Criscitiello C, Viale G. Curigliano G, et al. Among authors: marra a. Breast. 2020 Feb;49:202-209. doi: 10.1016/j.breast.2019.12.002. Epub 2019 Dec 12. Breast. 2020. PMID: 31869767 Free PMC article.
Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients.
Nichetti F, Ligorio F, Zattarin E, Signorelli D, Prelaj A, Proto C, Galli G, Marra A, Apollonio G, Porcu L, de Braud F, Lo Russo G, Ferrara R, Garassino MC. Nichetti F, et al. Among authors: marra a. Cancers (Basel). 2019 Dec 25;12(1):67. doi: 10.3390/cancers12010067. Cancers (Basel). 2019. PMID: 31881699 Free PMC article.
991 results